The Enterprise Value as of December 2025 (TTM) for Autobio Diagnostics Co., Ltd. (603658.SS) is 20.89B

According to Autobio Diagnostics Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.89B. This represents a change of -9.77% compared to the average of 23.15B of the last 4 quarters.

Autobio Diagnostics Co., Ltd. (603658.SS) Historical Enterprise Value (quarterly & annually)

How has 603658.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Autobio Diagnostics Co., Ltd. over the last ten years is 29.77B. The current 20.89B Enterprise Value has changed 6.92% with respect to the historical average. Over the past ten years (40 quarters), 603658.SS's Enterprise Value was at its highest in in the September 2020 quarter at 69.35B. The Enterprise Value was at its lowest in in the June 2016 quarter at 7.59B.

Autobio Diagnostics Co., Ltd. (603658.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Autobio Diagnostics Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Autobio Diagnostics Co., Ltd. (603658.SS) Average Enterprise Value

How has 603658.SS Enterprise Value performed in the past?

The current Enterprise Value of Autobio Diagnostics Co., Ltd. (603658.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Autobio Diagnostics Co., Ltd. (603658.SS) Enterprise Value vs. Peers

How is 603658.SS’s Enterprise Value compared to its peers?

Autobio Diagnostics Co., Ltd.’s Enterprise Value is greater than BGI Genomics Co., Ltd. (16.36B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (15.03B), greater than iRay Technology Company Limited (20.66B), less than Tasly Pharmaceutical Group Co., Ltd (21.25B), greater than China National Medicines Corporation Ltd. (16.96B), greater than Hubei Jumpcan Pharmaceutical Co., Ltd. (20.83B), less than Winner Medical Co., Ltd. (24.03B), less than DaShenLin Pharmaceutical Group Co., Ltd. (25.33B), greater than Double Medical Technology Inc. (18.94B), less than Liaoning Cheng Da Co., Ltd. (23.85B),

Build a custom stock screener for Autobio Diagnostics Co., Ltd. (603658.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Autobio Diagnostics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Autobio Diagnostics Co., Ltd. (603658.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Autobio Diagnostics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.